Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Saadi, Ali M.
- Evaluation of Liver Function in Type 2 Diabetic Patients during Clinical Trials in Kirkuk City
Abstract Views :160 |
PDF Views:0
Authors
Affiliations
1 Pathology Analysis Div., Hawija Technical Institute, Northern Technical University Kirkuk, IQ
2 Animal Production Div., Mosul Technical Institute, Northern Technical University Mosul, IQ
1 Pathology Analysis Div., Hawija Technical Institute, Northern Technical University Kirkuk, IQ
2 Animal Production Div., Mosul Technical Institute, Northern Technical University Mosul, IQ
Source
Research Journal of Pharmacy and Technology, Vol 12, No 4 (2019), Pagination: 1659-1663Abstract
Disease of diabetes mellitus is a condition for uncontrolled metabolism with an abnormally high level of glucose in the blood. Type II diabetes is a heterogeneous multi-faceted group of metabolic conditions described by high levels of glucose in the blood due to poor insulin and/or insulin secretion. In patients with type 2 diabetes, abnormalities in functional liver tests are not uncommon. The objective of this study is to investigate deviations in liver function from a group of diabetics in the city of Kirkuk and identify the factors associated with these changes in chemistry. A various primary health care centers were included with a total of 30 patients between March 2016 and August 2017 in Kirkuk. The results found that although the values of Alanine aminotransferase ALT, Aspartate aminotransferase AST were within a typical range, but there was a high significant increase in both values of patients than that of healthy subjects, ALT and AST were known (46.66%) and (43.33%) respectively. Also, no association in both ALT and AST with the sex of patients of diabetes. In addition, there was a weak positive relationship between each ALT and AST with BMI (0.1066), (0.1207), respectively. In conclusion, abnormalities in the consequences of liver function are more common among diabetics. Elevation in ALT, AST is a marker of non-alcoholic fatty liver disease in diabetic patients. Accordingly, the ALT and AST test should be performed to examine the primary fatty liver, especially with diabetes, with a high BMI.Keywords
ALT, AST, BMI, Liver Function, Obesity, Type Two Diabetes Mellitus.
References
- Agarawa J (2015). Prevalence of elevated hepatic enzymes among north Indian patients with type 2 diabetes mellitus. Santosh University Journal of Health Sciences;1(1), 3-6.
- American Diabetes Association (2015). Diagnosis and classification of diabetes mellitus. Diabetes Care.; 38(Suppl 1), S8-S16.
- Arrelias CCA, Faria HTG, Teixeira CRS, Santos MA, Zanetti ML (2015). Adherence to diabetes mellitus treatment and sociodemographic, clinical and metabolic control variables. Acta Paul Enferm.; 28(4), 315-22.
- Asselah, T.; Boyer, N.; Saadoun, D.; Martinot-Peignoux, M.; Marcellin, P(2016). Direct-acting antivirals for the treatment of hepatitis Cvirus infection: Optimizing current IFN-free treatment and future perspectives. Liver Int., 36, 47–57.
- Balaji AS (2014). Serum alanine transaminases and lipid profile in type 2 diabetes mellitus Indian patient. J Diab Res; [Epub ahead of print].
- Ballestri, S.; Nascimbeni, F.; Romagnoli, D.; Lonardo, A (2016). The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, alt and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment. Hepatol. Res.
- Belay Z, Daniel S, Tedla K, Gnanasekaran N (2014). Impairment of liver function tests and lipid profiles in type 2 diabetic patients treated at the diabetic center in Tikur Anbessa specialized teaching hospital (Tasth), Addis Ababa, Ethiopia. J Diabetes Metab 5,454.
- Byrne, C.D.; Targher, G (2015). NAFLD: A multisystem disease. J. Hepatol., 62, S47–S64.
- Durdi Q, Abdolkarim M, Ahad A, Parisa M, Saleh A, Ruzbeh B (2018). Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes. Journal of Diabetes and Metabolic Disorders 17, 1–10.
- Foster KJ, Dewbury K, Griffith AH, Price CP, Wright R(2013). Liver disease in patients with diabetes mellitus. Postgrad Med J, 56,20.
- Jalal M, Nisha N, Basheer S, Joseph N, Shobha P(2017). Association of Nonalcoholic Fatty Liver Disease with Insulin Resistance in Type 2 Diabetes Mellitus – A Prospective Study. J Fam Med, 4(4), 1119.
- Juliana VJ, Laercio JF (2018). The impact of diabetes mellitus on quality of life – differences between genders. Journal of Diabetes and Metabolic Disorders 17, 11–17.
- Liang S, Hang Y, Chunxiang W, Linjun X, Hua H, Xiaoquan L (2017). Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. Journal of Diabetes and Metabolic Disorders, 16, 45.
- Mehmet E O, Ioannis D K, Panoraia I S(2017). Diabetes Mellitus: A Review on Pathophysiology, Current Status of Oral Medications and Future Perspectives. Acta Pharmaceutica Sciencia 55(1),61-82.
- Noura A, Farah A, Sadia A, Mohammad F, Hajera T (2014). Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients. Int J Clin Exp Pathol;7(7), 4345-4349.
- Pedras S, Carvalho R,Pereira MG(2016).Sociodemographicand clinical characteristics of patients with diabetic foot ulcer. Rev Assoc Med Bras.; 62(2), 171-8.
- Perfect S, Choolwe J, Samuel B, Michael V, Patrick K, Charles M (2017). Risk factors for impaired fasting glucose or diabetes among HIV infected patients on ART in the Copperbelt Province of Zambia. Journal of Diabetes and Metabolic Disorders 16, 29.
- Petta, S, Valenti, L, Bugianesi, E, Targher, G, Bellentani, S, Bonino, F (2016). Special Interest Group on Personalised Hepatology of the Italian Association for the Study of the Liver (AISF). A “systems medicine” approach to the study of non-alcoholic fatty liver disease. Dig. Liver Dis., 48, 333–342.
- Philip R, Mathias M, Suchetha Kumari N. Damodara Gowda KM, Shetty KJ (2014). Evaluation of relationship between markers of liver function and the onset of type 2 diabetes. NUJHS;4(2),90-3.
- Pinho L, Aguiar APS, Oliveira MR, Barreto NAP, Ferreira CMM (2015). Hipertensão e dislipidemia em pacientes diabetes mellitus tipo 2: uma revisão integrativa. Rev Norte Mineira Enferm.; 4(1), 87-101.
- Prapaipan P, Weera S, Chutintorn S(2017). Concealed use of herbal and dietary supplements among Thai patients with type 2 diabetes mellitus. Journal of Diabetes and Metabolic Disorders 16, 36.
- Razi F, Katayoon F, Fatemeh B, Ensieh NE (2017). LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations. Journal of Diabetes and Metabolic Disorders, 16, 43.
- Raiza P, Michelle M, Suchetha K, Damodara G, Jayaprakash S(2014). Evalation of relationship between markers of liver function and the onset of type 2 diabetes. Nitte University Journal of Health Science; NUJHS 4(2), 90-93.
- Santos AL, Cecílio HPM, Teston EF, Arruda GO, Peternella FMN, Marcon SS (2015). Complicações microvasculares em diabéticos tipo 2 e fatores associados: inquérito telefônico de morbidade autorreferida. Ciênc Saúde Coletiva.; 20(3), 761-70
- Stefano B, Fabio N, Dante R, Enrica B, Giovanni T, Amedeo L(2016). Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight. Int. J. Mol. Sci. 17, 355
- Tsutomu Nishida (2017). Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test. Journal of the Endocrine Society, 1(7), 886–896.
- Waqas S, Tahir A, Nadeem S, Mohd R (2016). Type 2 diabetes mellitus: Link between diet, HbA1c and complications. AMJ. 9(9), 346–356.
- Zhang, Y.; Zhang, T.; Zhang, C.; Tang, F.; Zhong, N.; Li, H.; Song, X.; Lin, H.; Liu, Y.; Xue, F (2015). Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified bayesian network in a Chinese population. BMJ Open, 5, e008204.